Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology · DNAJC6-related parkinsonism (PARK19A)

Understanding the PARK19A Diagnosis

At a Glance

PARK19A is a rare inherited disorder caused by changes in both copies of the DNAJC6 gene. It may cause developmental delay or regression and movement problems in childhood, while some people develop slower, Parkinson-like symptoms between ages 20 and 50.

Receiving a diagnosis of PARK19A, also known as DNAJC6-related parkinsonism, often marks the end of a long and exhausting search for answers. This condition is exceptionally rare, with only a small number of families (kindreds) having been reported in medical literature worldwide [1]. It is natural to feel overwhelmed, but it is important to know that this is a genetic condition—nothing you did or did not do caused this to happen [2].

What is PARK19A?

PARK19A is an autosomal recessive genetic disorder, meaning a child must inherit two changed copies of the DNAJC6 gene (one from each parent) to develop the condition [3]. The DNAJC6 gene provides instructions for making a protein called auxilin [4].

Auxilin plays a critical role in the brain by helping recycle the small “bubbles” (synaptic vesicles) that carry chemical messengers between nerve cells. When this recycling process is disrupted due to a lack of auxilin, it leads to the movement and developmental challenges seen in PARK19A [4][3].

Two Main Ways the Condition Appears

Researchers have identified two primary clinical patterns that PARK19A can present itself. Reported phenotypes overlap and cannot be reliably forecast from the variant class alone [5].

  • Severe Juvenile Form (Childhood Onset): This pattern is often described in children. It often begins with neurodevelopmental delay (missing early milestones like crawling or walking) followed by neurological regression (losing skills previously gained) [4]. Symptoms typically appear before age 11 and can include parkinsonism (slow movement and stiffness) and dystonia (involuntary muscle contractions that cause twisting or repetitive movements) [4][1].
  • Early-Onset Adult Form: This is a typically milder reported pattern. It usually begins between the ages of 20 and 50 [3]. It often resembles typical Parkinson’s disease but occurs at a much younger age than usual. In these cases, the disease usually progresses more slowly and responds better to standard treatments [3].

Understanding the Symptoms

Because this condition is so rare, every child’s experience can be different. However, common clinical features reported in the severe juvenile form include:

  • Movement Issues: Generalized stiffness (rigidity), slow movement (bradykinesia), and tremors [4][1].
  • Cognitive and Behavioral Changes: Some children may experience shifts in learning ability or behavior as the condition progresses [1].
  • Seizures: While not present in every case, epilepsy (recurrent seizures) has been documented in several children with this diagnosis [1][6].
  • Bulbar Symptoms: This refers to difficulties with swallowing (dysphagia) or managing saliva [1].

The Emotional Journey and Family Planning

The “diagnostic odyssey”—the long period of seeing multiple doctors and undergoing various tests before getting an answer—is incredibly taxing. Many parents report feeling a complex mix of relief at finally having a name for the condition, alongside deep anxiety, frustration, and sadness about the future [7][2].

If both parents are confirmed carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of inheriting neither familial variant. A genetic counselor can discuss reproductive options. Studies show that parents of children with rare genetic syndromes often experience higher levels of distress than those in other groups [8]. It is common to feel:

  • Guilt: Even though genetic mutations are random and unavoidable, many parents feel a sense of responsibility [9].
  • Isolation: Because the condition is so rare, it can be hard to find others who truly understand what you are going through [10].
  • Uncertainty: The rarity of PARK19A means there is often less information available about what to expect long-term compared to more common conditions [9].

Connecting with rare disease communities and specialized medical teams can help reduce this isolation and provide practical tips for daily care [10][11]. Your care team is there to help you navigate these feelings and plan for your child’s specific needs.

Common questions in this guide

What is PARK19A and what causes it?
PARK19A, also called DNAJC6-related parkinsonism, is a rare inherited condition affecting brain processes involved in movement and development. It occurs when a child inherits two changed copies of the DNAJC6 gene, one from each parent.
What symptoms can a child with PARK19A develop?
The severe childhood pattern may cause developmental delay followed by loss of skills, stiffness, slow movement, tremor, dystonia, learning or behavior changes, seizures, and difficulty swallowing or managing saliva. Not every child has all of these symptoms.
Does PARK19A affect everyone in the same way?
No. Reported patterns range from a severe childhood form that often starts before age 11 to a milder adult form that usually begins between ages 20 and 50. The specific type of DNAJC6 change alone cannot reliably predict which pattern a person will have.
What does a PARK19A diagnosis mean for future pregnancies?
If both parents carry one altered DNAJC6 copy, each pregnancy has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of inheriting neither family variant. A genetic counselor can explain these chances and discuss reproductive options.
Can people with PARK19A respond to Parkinson's treatments?
The early-onset adult pattern is reported to progress more slowly and respond better to standard Parkinson's treatments. Treatment response can vary, so a neurology team should tailor care to the person's symptoms and clinical pattern.
How can families find support after a PARK19A diagnosis?
It is common for parents to feel relief, anxiety, guilt, isolation, or uncertainty after a rare diagnosis. A specialized care team, genetic counselor, and rare-disease community or advocacy organization can provide information, practical ideas, and connection with other families.

Get notified when new evidence is published on Juvenile onset Parkinson disease 19A.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Childhood-onset parkinsonism, dystonia and severe muscle wasting in a Sudanese girl caused by a novel homozygous DnaJ heat shock protein family (heat shock protein 40) member C6 frameshift variant, with an incidental pathogenic breast cancer 1 gene secondary finding: a case report.

    Ahmed KAHM, Ahmed RKY

    Journal of medical case reports 2026; (20(1)).

    PMID: 42897672
  2. 2

    Understanding the Psychosocial Effects of WES Test Results on Parents of Children with Rare Diseases.

    Krabbenborg L, Vissers LE, Schieving J, et al.

    Journal of genetic counseling 2016; (25(6)):1207-1214 doi:10.1007/s10897-016-9958-5.

    PMID: 27098417
  3. 3

    DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.

    Olgiati S, Quadri M, Fang M, et al.

    Annals of neurology 2016; (79(2)):244-56 doi:10.1002/ana.24553.

    PMID: 26528954
  4. 4

    DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia.

    Ng J, Cortès-Saladelafont E, Abela L, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(8)):1357-1368 doi:10.1002/mds.28063.

    PMID: 32472658
  5. 5

    The genetic landscape of Parkinson's disease.

    Lunati A, Lesage S, Brice A

    Revue neurologique 2018; (174(9)):628-643 doi:10.1016/j.neurol.2018.08.004.

    PMID: 30245141
  6. 6

    Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism.

    Pessoa ALS, Guimarães TG, de Castro Dos Santos D, et al.

    Movement disorders clinical practice 2026; doi:10.1002/mdc3.70731.

    PMID: 42414182
  7. 7

    Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.

    Zurynski Y, Deverell M, Dalkeith T, et al.

    Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.

    PMID: 28399928
  8. 8

    Parental stress and adjustment in the context of rare genetic syndromes: A scoping review.

    Fitzgerald J, Gallagher L

    Journal of intellectual disabilities : JOID 2022; (26(2)):522 - 544 doi:10.1177/1744629521995378.

    PMID: 33866895
  9. 9

    The supportive care needs of parents caring for a child with a rare disease: A scoping review.

    Pelentsov LJ, Laws TA, Esterman AJ

    Disability and health journal 2015; (8(4)):475-91.

    PMID: 25959710
  10. 10

    Attitudes about the use of internet support groups and the impact among parents of children with Cornelia de Lange syndrome.

    Cacioppo CN, Conway LJ, Mehta D, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2016; (172(2)):229-36 doi:10.1002/ajmg.c.31504.

    PMID: 27163126
  11. 11

    The Association between Healthcare Satisfaction and Social Support and Stress, Depression, and Life Satisfaction in Female Caregivers: The Moderating Role of Dependence of a Sick Child.

    Pavić J, Krznar M, Čukljek S, et al.

    International journal of environmental research and public health 2024; (21(9)) doi:10.3390/ijerph21091245.

    PMID: 39338128

This page about PARK19A is for informational purposes only and does not constitute medical advice. Your child's medical team and a genetic counselor can interpret the diagnosis and discuss individualized care and family-planning options.